Why the study?
Accessible and affordable predictive factors are needed to prevent and treat arteriovenous fistula dysfunction, with the neutrophil-to-lymphocyte count recently examined as a potential risk factor in hemodialysis patients.
Is the neutrophil-to-lymphocyte ratio associated with arteriovenous fistula dysfunction in hemodialysis patients?
Is the neutrophil-to-lymphocyte ratio associated with arteriovenous fistula dysfunction in hemodialysis patients?
In a small cross-sectional study, the neutrophil-to-lymphocyte ratio was not significantly associated with arteriovenous fistula dysfunction in hemodialysis patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bahari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: